FDA Inspection 1099082 — Jonathan Dosik, M.D.

Jonathan Dosik, M.D. — FEI 3012261314

The FDA completed an inspection of Jonathan Dosik, M.D. on Jul 23, 2019 in Fair Lawn, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 23, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fair Lawn, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.